Latest Industry News & Trends

Ophthalmologists Report 5.5 Percent Increase in Q3-2024 Procedure Volume

US ophthalmologists reported that ophthalmic procedures increased 5.5 percent in Q3-2024 compared with the same quarter in 2023, according to Market Scope’s latest survey. Year-over-year performanc...

Asia-Pacific Markets and Lens-Based Procedures Drive Refractive Surgery

Economic conditions continue to be cited as the reason for flat or declining laser-vision correction (LVC)surgery rates in some markets in 2024. However, a shift in refractive surgery types and hig...

Zeiss Gains US Approval for Next-Gen MEL 90 Excimer Laser

Carl Zeiss Meditec gained US FDA approval on Dec. 4 for its MEL 90 excimer laser, the next-generation iteration of its MEL 80 for LASIK surgery. The MEL 90’s US labeling is for correction of myopia...

2025-2026 Ophthalmic Meetings Calendar

Market Scope regularly updates its list of ophthalmic meetings to keep the information current. Please contact us at matthewdouty@market-scope.com if we do not have your meeting listed. Thank you.

December 2024 Ophthalmic News Briefs

Dutch company Ophtec announced Nov. 18 that it had gained CE marking for its Artiplus phakic IOL. The company said the lens offered a solution for relatively young presbyopes, typically in their ea...

Zeiss Gains US Approval for MEL 90 Excimer Laser

Carl Zeiss Meditec gained US FDA approval on Dec. 4 for its MEL 90 excimer laser, the next-generation iteration of its MEL 80 for LASIK surgery. The MEL 90’s US labeling is for correction of myopia...

Ophtec Receives CE Marking for Artiplus Phakic IOL, Targets Young Presbyopes

Dutch company Ophtec announced Nov. 18 that it had gained CE Mark approval for its Artiplus phakic intraocular lens (IOL). The company said the lens offered a solution for relatively young presbyop...

Q3-2024 Ophthalmic Revenue Roundup for AbbVie, Apellis, Glaukos, STAAR, and Lensar

AbbVie, of North Chicago, Illinois, reported Oct. 30 that its Q3-2024 eye care net revenue was $525 million, a 13.5 percent decline (-11.2 percent cc) from $605 million in Q3-2023. Restasis revenue...

Ocuphire Pharma Acquires Opus Genetics, Will Operate Under Opus Name

Ocuphire Pharma announced Oct. 22 that it would acquire Opus Genetics in an all-stock transaction. The combined company will operate under the Opus name and will trade on the Nasdaq under the ticke...

Hyperopia Treatment Using Lenticule Extraction Showcased to Eager European Ophthalmologists

Dan Reinstein, MD (UK), shared during an overly full symposium at the 2024 ESCRS congress his experience using Zeiss’ SMILE lenticule extraction procedure to treat hyperopic patients. Zeiss is the ...

Bausch + Lomb Launches Octavius Topo-Guided Treatment at ESCRS Congress

Bausch + Lomb showcased its CE marked Octavius at the 2024 ESCRS Congress. Octavius is a new treatment mode on the Teneo excimer laser that uses data from multiple diagnostic platforms to provide a...

FTC Sends More Than $1.1 Million to Consumers Misled by LCA-Vision Ads

The Federal Trade Commission (FTC) announced Oct. 3 that it was sending more than $1.1 million in settlement payments to consumers who were misled by deceptive bait-and-switch advertising by LCA-Vi...

Weekly Surgeon Poll, October 2024

FTC Sends More Than $1.1 Million to Consumers Misled by LCA-Vision Ads

The Federal Trade Commission (FTC) announced Oct. 3 that it was sending more than $1.1 million in settlement payments to consumers who were misled by deceptive bait-and-switch advertising by LCA-Vi...

Ophthalmologists Report 0.5 Percent Increase in Q2-2024 Procedure Volume

US ophthalmologists reported that ophthalmic procedures increased 0.5 percent in Q2-2024 compared with the same quarter in 2023, according to Market Scope’s latest survey. Year-over-year performanc...

Zeiss Plans to Use Creal's Technology to Reimagine Refractive Exams

Zeiss will integrate Swiss company Creal’s light field display technology into its refractive diagnostic equipment under a collaboration agreement, the two companies reported Sept. 10. Creal descri...

Zeiss Plans to Use Creal's Technology to Reimagine Refractive Exams

Zeiss will integrate Swiss company Creal’s light field display technology into its refractive diagnostic equipment under a collaboration agreement, the two companies reported Sept. 10. Creal descri...

Carl Zeiss Meditec Introduces Hyperopia Treatment Using Lenticule Extraction

German company Carl Zeiss Meditec reported Aug. 24 that it had become the first medical device manufacturer to introduce in the CE market the treatment of hyperopia using lenticule extraction. This...

OHSU Researchers Discover Link Between Proteins in Tears, Pain After Eye Surgery

Researchers at Oregon Health & Science University (OHSU) say they have discovered a connection between postsurgical ocular pain and levels of certain proteins found in patients’ tears. Some patient...

Meet with Market Scope at the 2024 ESCRS Congress

Market Scope will be exhibiting at the 2024 ESCRS congress, which is Sept. 6-10 in Barcelona, Spain. We will be located at Stand 6.D12. Contact us to set up a time to discuss any custom research ne...

Q2-2024 Ophthalmic Revenue Roundup for AbbVie, Carl Zeiss Meditec, Amgen, STAAR, Astellas, Immunocore, Tarsus, Biogen, Lensar, and Iridex

AbbVie, of North Chicago, Illinois, reported July 25 that Q2-2024 net revenue for its eye care products totaled $533 million, a 13.3 percent decline (-10.9 percent cc) from $617 million in Q2-2023....

OHSU Researchers Discover Link Between Proteins in Tears, Pain After Eye Surgery

Researchers at Oregon Health & Science University (OHSU) say they have discovered a connection between postsurgical ocular pain and levels of certain proteins found in patients’ tears. Some patient...

Ophthalmic Chain in Colorado Closing All Six Clinics, Citing COVID-19 Financial Fallout

Rocky Mountain Eye Center, based in Pueblo, Colorado, announced on its website that it will close all of its six clinics on July 31, saying the practice was unable to recover from the financial fal...

Ophthalmic Chain in Colorado Closing All Six Clinics, Citing COVID-19 Financial Fallout

Rocky Mountain Eye Center, based in Pueblo, Colorado, announced on its website that it will close all of its six clinics on July 31, saying the practice was unable to recover from the financial fal...

Ophthalmology Chain Clínica Baviera Enters UK Market with Acquisition of Optimax

European ophthalmology chain Clínica Baviera has extended its reach into the UK with the purchase of Optimax. Optimax (Eye Hospitals Group and subsidiaries) operates 19 clinics under the Optimax an...

J&J Leads Series A Round for Crosslinking Tech Developer TecLens

Johnson & Johnson is the lead investor in a Series A funding round for Stamford, Connecticut-based TecLens, developer of a new crosslinking technology, J&J announced June 21. The technology is inte...

Evolution Optiks Receives US FDA 510(k) Clearance for Tele-refactor

Barbados-based Evolution Optiks announced June 4 that it had received 510(k) clearance from the US FDA for the LFR-260, its light field powered subjective tele-refractor. The device gained CE marki...

Ophthalmologists Report 6 Percent Decline in Q1-2024 Procedure Volume

US ophthalmologists reported that ophthalmic procedures decreased 6.0 percent in Q1-2024 compared with the same quarter in 2023, according to Market Scope’s latest survey. Year-over-year performanc...

June 2024 Ophthalmic News Briefs

Japan’s Nidek announced June 3 that it had launched the RS-1 Glauvas OCT system. The device is CE marked as a Class IIa device. Nidek said the RS-1 Glauvas’ streamlined workflow and advanced analyt...

Sightpath Medical Acquires LASIK Services Business PennVista

Sightpath Medical announced May 30 that it had acquired PennVista, a LASIK services business operating in Pennsylvania, Ohio, West Virginia, Indiana, and Michigan. Financial details were not disclo...

Clinical Trial Updates for Ophthalmic Candidates, May 2024

Market Scope is tracking companies that have announced clinical trial updates or milestone achievements.

Q1-2024 Ophthalmic Revenue Roundup for Apellis, STAAR, RxSight, Tarsus, Sight Sciences, and Three Others

Apellis Pharmaceuticals, of Waltham, Massachusetts, reported May 7 that its Q1-2024 US net product revenue for Syfovre was $137.5 million, compared with $18.4 million in Q1-2023. Syfovre gained US ...

Bausch + Lomb Launches Zenlens Echo Scleral Lenses in the US

Bausch + Lomb announced May 7 that it had launched the Zenlens Echo, a non-prosthetic, custom scleral contact lens, in the US. The company said the Echo is designed to fit a wide variety of corneal...

ArcScan Computer-Controlled Ophthalmic Ultrasound Gains Approval in China

ArcScan announced May 1 that its Insight 100 computer-controlled ophthalmic ultrasound imaging device received National Medical Products Administration (NMPA) approval in China. ArcScan, of Denver,...

New Products Set Upbeat Tone for ASCRS Meeting; Attendance Remains a Concern

New product launches created high surgeon interest at the 2024 meeting of the American Society of Cataract and Refractive Surgery (ASCRS), but the overall mood of the conference was tempered somewh...

Refractive Atlas Uncovers Pockets of High Opportunity in Des Moines, Syracuse

Refractive procedures in general are driven by the country’s millennial and older Generation Z populations, but the surgery rate is driven by a subset of comparatively educated, affluent, and healt...

Viatris, Ocuphire Announce US Launch of Ryzumvi to Reverse Pupil Dilation

Viatris and Ocuphire Pharma announced April 1 the US launch of Ryzumvi (phentolamine ophthalmic solution) 0.75% for the reversal of pharmacologically induced mydriasis. The US FDA approved Ryzumvi ...

Slade’s Steinert Lecture Bolsters Value of Refractive Lens Exchange

Stephen Slade, MD, promoted the value of refractive lens exchange (RLE) during the Steinert Lecture at the 2024 ASCRS meeting’s Refractive Subspecialty Day. RLE is an elective procedure that remove...

ASCRS Meeting Showcases New Lenticule Extraction Platforms

Lenticule extraction (LE) continues to advance as new platforms come to the market. The 2024 ASCRS meeting showcased improved LE features that have enhanced the patient and surgeon experience. Doct...

Dry Eye Screening Before Surgery Seems Logical, but Hurdles Remain

The need to continue lobbying for dry eye evaluation prior to patients undergoing anterior segment surgery is somewhat baffling. Such testing seems like an obvious approach for the many patients wh...

Alcon Appoints Terry Kim, MD, as CMO, Head of Global Medical Safety

Alcon announced March 26 that Terry Kim, MD, would join the company in April as chief medical officer (CMO) and head of global medical safety. Kim, who specializes in cornea, cataract, and refracti...

Santen Files for Marketing Approval in Japan for Atropine Drops to Delay Myopia

Santen Pharmaceutical announced Feb. 28 that it had filed for marketing approval in Japan for DE-127 (0.025% atropine sulfate hydrate eye drop), designed to slow the progression of myopia. The prod...

FTC Sends Settlement Notices to Potential Victims of Bait-and-Switch LASIK Ads

The Federal Trade Commission has sent notices to about 160 thousand individuals who received LASIK consultations at LasikPlus or Joffe MediCenter that they may be eligible for a settlement payout. ...

Select US FDA Approvals and Clearances in February 2024

The US FDA granted two clearances through the ophthalmic device division using the 510(k) pathway in February 2024, according to the agency’s database. CATS Tonometer received clearance for its ton...

Santen Files for Marketing Approval in Japan for Atropine Drops to Delay Myopia

Santen Pharmaceutical announced Feb. 28 that it had filed for marketing approval in Japan of DE-127 (0.025% atropine sulfate hydrate eye drop), designed to slow the progression of myopia. The produ...

FTC Sends Settlement Notices to Potential Victims of Bait-and-Switch LASIK Ads

The Federal Trade Commission has sent notices to about 160 thousand individuals who received LASIK consultations at LasikPlus or Joffe MediCenter that they may be eligible for a settlement payout. ...

2023 Ophthalmic Revenue Roundup for Alcon, Bausch + Lomb, STAAR, Glaukos, Apellis, and Tarsus

Alcon reported Feb. 27 that its full year 2023 net sales totaled $9.4 billion, an 8 percent increase (+10 percent cc) over $8.7 billion in 2022. Q4-2023 sales were $2.3 billion, an 8 percent increa...

Bausch + Lomb Teneo Excimer Laser Enters US Market After Drought in New Technology

A new excimer laser has entered the US refractive market for the first time in nearly two decades. Bausch + Lomb announced in January that the US FDA had approved the Teneo excimer laser platform f...

Select US FDA Approvals and Clearances in January 2024

The US FDA granted two clearances through the ophthalmic device division using the 510(k) pathway in January 2024, according to the agency’s database. Meridian received clearance for three laser mo...

Ophthalmic Quarterly Revenue Roundup for Carl Zeiss Meditec and Hoya

Carl Zeiss Meditec reported Feb. 9 that ophthalmology revenue for the last three months of 2023, its first quarter of fiscal year 2023/2024, totaled €351.1 million ($378.5 million, converted Feb. 9...

Ace Vision Group Names Val Kolesnitchenko, MD, as Chief Scientific Officer

Ace Vision Group announced Feb. 13 that it had named Val Kolesnitchenko, MD, as chief scientific officer. Most recently, Kolesnitchenko held the position of executive director of global scientific ...

2023 in Review: Bausch + Lomb Makes Big Moves, Adding Product Lines and Building Partnerships

Bausch + Lomb made a flurry of big moves in 2023, with product approvals, acquisitions, leadership changes, and strategic partnerships and collaborations following the company’s IPO in mid-2022. In...

Carl Zeiss Meditec’s VisuMax 800 and SMILE Software Gain US FDA Approval

Carl Zeiss Meditec reported Jan. 11 that the US FDA had approved its updated VisuMax 800 femtosecond refractive laser and related SMILE software for surgically treating nearsightedness with or with...

Eyenovia Reacquires Rights to MicroPine in US, Canada from Bausch + Lomb

Eyenovia announced Jan. 16 that it had reacquired the rights to pediatric myopia candidate MicroPine in the US and Canada from Bausch + Lomb. The investigational formulation of atropine, intended f...

US FDA Approves Teneo Excimer Laser Platform from Bausch + Lomb for LASIK Vision Correction

Bausch + Lomb announced Jan. 8 that the US FDA had approved the Teneo excimer laser platform for laser-assisted in situ keratomileusis (LASIK) vision correction surgery for myopia and myopic astigm...

Carl Zeiss Meditec’s Updated VisuMax 800 and SMILE Software Gain US FDA Approval

Carl Zeiss Meditec reported Jan. 11 that the US FDA had approved its updated VisuMax 800 femtosecond refractive laser and related SMILE software for surgically treating nearsightedness with or with...

Ophthalmologists Report 6.4 Percent Decline in Q3-2023 Procedure Volume

US ophthalmologists reported that ophthalmic procedures decreased 6.4 percent in Q3-2023 compared with the same quarter in 2022, according to Market Scope’s latest survey. Year-over-year performanc...

Select US FDA Approvals and Clearances in November 2023

The US FDA granted three clearances through the ophthalmic device division using the 510(k) pathway in November 2023, according to the agency’s database. Medimaging Integrated Solution (MiiS) recei...

Weekly Surgeon Poll, December 2023

US Refractive Surgeons Grapple with Treatment Options for High Myopes

Surgeons attending the Refractive Subspecialty Day at the 2023 AAO meeting in San Francisco debated the ideal treatment options for patients with moderate to high myopia. Practices shared widely di...

STAAR Surgical Celebrates ICL Procedure’s 30th Anniversary

STAAR Surgical reported Oct. 17 that October 2023 marked the 30th anniversary of the first implantations of the company’s Implantable Collamer Lens (ICL). The lens is intended to be implanted betwe...

Buzzworthy Topics at the 2023 AAO Meeting

Dry Eye: New products kept generating buzz around dry eye. Bausch + Lomb leaned into the promotion of Miebo, the new, first-in-class drug therapy that directly targets tear evaporation. Diagnostic ...

Ace Vision Group Names Rob Kissling, MD, as Chief Medical Officer

Laser company Ace Vision Group announced Nov. 1 that it had named Rob Kissling, MD, as chief medical officer. Most recently, Kissling served as vice president of clinical and medical affairs at Bau...

Q3-2023 Ophthalmic Revenue Roundup for Regeneron, Bausch + Lomb, AbbVie, and Five Others

Regeneron of Tarrytown, New York, reported Nov. 2 that its Q3-2023 US revenue for Eylea (aflibercept) 2 mg and Eylea HD (a higher dose of aflibercept at 8 mg) was $1.49 billion, with Eylea HD accou...

Futures Forums Cater to Companies that Can’t Gain Limelight Elsewhere, Co-founder Says

Kuldev Singh, MD (US), co-founder of Europe’s annual Ophthalmology Futures Forums (OFF), told Market Scope in October that he takes pride in the group’s record of giving “people with new ideas who ...

Lenticule Extraction Procedures Poised for Boost as Fourth Platform Enters Market at ESCRS

Johnson & Johnson Vision announced the launch of the Elita platform’s lenticule extraction (LE) procedure during the 2023 congress of the European Society of Cataract and Refractive Surgeons. The s...

ISOP Meeting Analyzes ‘Phacorestoration’ and ‘Presbyopia Botox’

The International Society of Presbyopia highlighted new treatment approaches that come with some interesting names. The conference was held Sept. 7 at the Vienna Marriott Hotel in Vienna, Austria. ...

STAAR Surgical Celebrates ICL Procedure’s 30th Anniversary

STAAR Surgical reported Oct. 17 that October 2023 marked the 30th anniversary of the first implantations of the company’s Implantable Collamer Lens (ICL). The lens is intended to be implanted betwe...

Ophthalmologists Report 4.9 Percent Decrease in Q2-2023 Procedure Volume

US ophthalmologists reported that ophthalmic procedures decreased 4.9 percent in Q2-2023 compared with the same quarter in 2022, according to Market Scope’s latest survey. Year-over-year performanc...

Ophthalmic Diagnostic Equipment Market To Grow 3.8 Percent Through 2028, Driven by OCT Systems

Market Scope estimates that the ophthalmic diagnostic equipment market will generate $3.7 billion in total revenue in 2023, and the market will grow to $4.4 billion by 2028, for a compound annual g...

September 2023 Ophthalmic News Briefs

Carl Zeiss Meditec announced Aug. 23 that more than 8 million eyes had been treated with the company’s SMILE procedure through the first half of 2023. SMILE, short for small-incision lenticule extr...

Carl Zeiss Meditec Surpasses 8 Million Total SMILE Procedures in First Half of 2023

Carl Zeiss Meditec announced Aug. 23 that more than 8 million eyes had been treated with the company’s SMILE procedure through the first half of 2023. SMILE, short for small-incision lenticule extr...

Refractive Surgeons’ Panel Recommends Updates to Terminology

The Refractive Surgery Alliance Terminology Committee has proposed updates to the terminology for two procedures and one postoperative complication—changes that the panel says will improve doctor c...

US FDA Target Action Dates for Ophthalmic Drug Candidates, August to December 2023

The US FDA has scheduled the following Prescription Drug User Fee Act (PDUFA) target action dates for ophthalmic prescription and biologic drug candidates and those classified as drug/device combin...